Terms: = Liver cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Prognosis
10 results:
1. Prognostic value of genotyping in hepatocellular carcinoma: A systematic review.
Bodard S; Liu Y; Guinebert S; Yousra K; Asselah T
J Viral Hepat; 2023 Jul; 30(7):582-587. PubMed ID: 36922710
[TBL] [Abstract] [Full Text] [Related]
2. Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression.
Cabiati M; Gaggini M; De Simone P; Del Ry S
Clin Exp Metastasis; 2022 Aug; 39(4):589-602. PubMed ID: 35429302
[TBL] [Abstract] [Full Text] [Related]
3. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
Matsuda Y; Yamashita T; Ye J; Yasukawa M; Yamakawa K; Mukai Y; Machitani M; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Yamada S; Takei J; Kaneko MK; Kojima M; Kaneko S; Masaki T; Hirata M; Haba R; Kontani K; Kanaji N; Miyatake N; Okano K; Kato Y; Masutomi K
J Pathol; 2022 Jun; 257(2):172-185. PubMed ID: 35094384
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analysis of the casp gene family in relation to survival, tumor-infiltrating immune cells and therapeutic targets.
Hong W; Gu Y; Guan R; Xie D; Zhou H; Yu M
Genomics; 2020 Nov; 112(6):4304-4315. PubMed ID: 32682809
[TBL] [Abstract] [Full Text] [Related]
5. [Exploring of a prognostic long non-coding RNA signature of hepatocellular carcinoma by using public database].
Xiao JR; Wang K; Liu Y; Li ZW; Zhou YJ; Wang HZ; Lu JY; Cheng SS; Wei S
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jul; 40(7):805-809. PubMed ID: 31357803
[No Abstract] [Full Text] [Related]
6. The significance of prophylactic transarterial chemoembolization after radical resection of small hepatocellular carcinoma: A retrospective analysis.
Fan S; Yu B; Wang X
J Cancer Res Ther; 2017; 13(5):773-777. PubMed ID: 29237902
[TBL] [Abstract] [Full Text] [Related]
7. Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma.
Shi L; Yan P; Liang Y; Sun Y; Shen J; Zhou S; Lin H; Liang X; Cai X
Cell Death Dis; 2017 Nov; 8(11):e3171. PubMed ID: 29144509
[TBL] [Abstract] [Full Text] [Related]
8. caspase polymorphisms and prognosis of hepatocellular carcinoma.
Zhang S; Xiao Q; Shi Z; Yu G; Ma XP; Chen H; Zhang P; Shen S; Sai-Yin HG; Chen TY; Lu PX; Wang NJ; Ren W; Huang P; Xie J; Conran C; Zheng SL; Yu L; Xu J; Jiang DK
PLoS One; 2017; 12(4):e0176802. PubMed ID: 28453560
[TBL] [Abstract] [Full Text] [Related]
9. Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database.
Cohen MJ; Levy I; Barak O; Bloom AI; Fernández-Ruiz M; Di Maio M; Perrone F; Poon RT; Shouval D; Yau T; Shibolet O
Liver Int; 2014 Aug; 34(7):1109-17. PubMed ID: 24512125
[TBL] [Abstract] [Full Text] [Related]
10. Carcinoma of the body of pancreas in evolution: an aggressive disease affecting younger patients?
Dickinson KJ; Gomez D; Lowe A; Gokhale JA; Ausobsky JR; Guillou PJ; Rahman SH
JOP; 2007 May; 8(3):312-9. PubMed ID: 17495360
[TBL] [Abstract] [Full Text] [Related]
